- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/12 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
Patent holdings for IPC class C07D 295/12
Total number of patents in this class: 181
10-year publication summary
|
8
|
8
|
2
|
9
|
4
|
2
|
10
|
6
|
8
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1150 |
17 |
| Astellas Pharma Inc. | 1085 |
8 |
| Toyama Chemical Co., Ltd. | 102 |
5 |
| Janssen Pharmaceutica N.V. | 3395 |
4 |
| BioMarin Pharmaceutical Inc. | 376 |
4 |
| Exonhit Therapeutics SA | 26 |
4 |
| Laboratorios Del Dr. Esteve, S.A. | 172 |
4 |
| Glaxosmithkline LLC | 537 |
3 |
| Arete Therapeutics, Inc. | 23 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
3 |
| Glaxo Group Limited | 4080 |
2 |
| F. Hoffmann-La Roche AG | 7930 |
2 |
| Allergan, Inc. | 2349 |
2 |
| The Board of Trustees of the University of Illinois | 2687 |
2 |
| Takeda Pharmaceutical Company Limited | 2714 |
2 |
| Arrow Therapeutics Limited | 13 |
2 |
| Bioprojet | 42 |
2 |
| Grünenthal GmbH | 572 |
2 |
| Institut Pasteur Korea | 47 |
2 |
| Institute of Medicinal Molecular Design, Inc. | 8 |
2 |
| Other owners | 106 |